Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • blueskypy
    Junior Member
    • May 2013
    • 3

    #16
    Here is a reply from the GATK team:
    Well, the thing to keep in mind is that if you merge all your BAMs together into a big one, the processing of that big BAM is going to be very computationally demanding. Also, note that the recalibrator will process read groups individually, so you will not get the "whole lane data" advantage that you think from recalibrating multiple samples together.
    Actually, let me take a step back and give you a quick run-down of what we do in-house.
    Our setup is a bit complex because we have samples spread over multiple lanes, with multiple samples per lane. So when we get the FastQs, we separate out the read data by read group into individual files, so that after alignment we have one bam file per read group. We run dedup-realign-recal on each bam file, then merge the bams of read groups that belong to the same sample to produce one bam file per sample. Then we do another round of realign-recal on the sample bams as a form of cross-lane cleanup.
    But if you don't have samples spread across different lanes, you don't need to do all of this. The simplest is probably to separate out the samples using their read group tags into individual bam files and process them separately through dedup-realign-recal. I realize this contradicts what I said earlier; technically that (earlier suggestion to just process all together) is still an option (with some advantages, e.g. all samples aligned the same way), but if you plan to split up your samples before variant calling anyway, you might as well split everything earlier on and save yourself the compute resources of processing everything together.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...